InDex Pharmaceuticals has announced that its CEO Jenny Sundqvist and its CFO & Deputy CEO Johan Giléus will leave the company per September 26, 2024. Jenny Sundqvist and Johan Giléus
NOT A SUBSCRIBER? SIGN UP TODAY AND GET THE FULL LIFE SCIENCE PICTURE
ONLY 13 €/MONTH
NLS News
Braincool announces that it is reporting its former CEO to the police over a prohibited loan, and that it will have to raise capital of SEK 85-95 million. The police
A SEK 7.7 million investment is being made into the BRIDGE Sweden project, designed to streamline the journey from research to commercialization of biological pharmaceuticals and precision medicine. Running for
The company has received SEK 5 million from Eurostars in a collaborative project with the French biotech company Okomera. The funding is intended to strengthen the development of an analysis
Novo Nordisk has agreed to acquire Cardior for up to EUR 1.025 billion, including an upfront payment and additional payments if certain development and commercial milestones are achieved. Cardior is
The company has been awarded up to EUR 10 million in grant and equity financing by the European Innovation Council (EIC) Accelerator program to support the company through key milestones
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending marketing authorization for Awiqli (the brand name for once-weekly basal insulin icodec)
Jeppe Øvlesen has been appointed new CEO, succeeding Torbjørn Bjerke, effective immediately due to a disagreement over the company’s strategy. The decision was reached following an extraordinary general meeting and
“The goal is for an organization with at least 500 employees to set up operations here. We already have the infrastructure needed to make us attractive to larger companies,” says
BioArctic’s founder, Professor Lars Lannfelt, was awarded the European Grand Prix for his research on Alzheimer’s disease at the anniversary gala for La Fondation Recherche Alzheimer in Paris on March
Read about seven trends that are shaping the life science sector right now, including concrete examples from Gothenburg. Experts at Business Region Göteborg have summarized seven particularly hot areas where
AstraZeneca has entered into a definitive agreement to acquire Canadian Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs). Under the terms of the definitive agreement, AstraZeneca, through a
Sponsored content
Vitality: Understanding the lifespan of vaporized H2O2 sensors
A unique feature of the HPP270 series probes is the ability to evaluate the sensors’ performance through its “Sensor Vitality” value. This value is like a health check for the sensor.
Drug and Device Development
Orexo and Swedish Orphan Biovitrum (Sobi) have agreed to advance their exploratory feasibility study with AmorphOX initiated last year. The feasibility study primarily assessed whether the biomolecule could be formulated
Sobi has announced results from the AVA-PED-301 study, evaluating the efficacy and safety of avatrombopag (Doptelet) for the treatment of paediatric patients with immune thrombocytopenia (ITP) of at least 6
Nykode Therapeutics has announced key conclusions from the updated analysis from the Phase 2 VB-C-02 trial. The trial investigates the use of Nykode’s wholly-owned off-the-shelf therapeutic cancer vaccine candidate VB10.16
Predicting 2024
Nordic Life Science asked Lene Gerlach, Partner, Eir Ventures, about her predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you predict will
Nordic Life Science asked Casper Breum, Managing Partner, Sound Bioventures, about his predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you predict
Nordic Life Science asked Ingrid Teigland Akay, Managing Partner, Hadean Ventures, about her predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you
Nordic Life Science asked Dan Akschuti, Equity Partner/Biotech Analyst, Pareto Securities, about his predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you
Nordic Life Science asked Pekka Simula, Partner, Innovestor Life Science, about his predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you predict
Careers
Promotions and hefty raises do not create leaders. While some people always want to sit in the driver’s seat, leadership – effective leadership – is a learned skill. Too often
Jeanette Edblad is the new Director of the Office for Life Sciences at the Government Offices in Sweden. NLS asked her about her new role and about Swedish life sciences.
The board of WntResearch has appointed Per Norlén as the company’s new CEO. Per Norlén has solid experience from the life science industry in general and the development of cancer
Careers
Nordic Life Science had a chat with last year’s winner of the award Female Leader Engineer, Katarina Atteryd, about the award’s impact on her career and her thoughts on leadership,
JOB ALERTS
Read the latest issue of our magazine!
No 01 2024 // Many scientists state that we are entering the golden age of CNS disease treatment. Learn more about some of the most recent progress being made within the field, including Nordic advances. This issue’s profile is professor Mia Phillipson, co-founder of Ilya Pharma, co-director at SciLifeLab, a member of the Royal Swedish Academy of Sciences, and a scientist pioneering immunotherapies. We have a special report on the life science financial landscape, including VC predictions for 2024, an interview with Thomas Eldered, Flerie Invest, and a global outlook. This issue also includes a special focus on the skills shortages within cell and gene therapy manufacturing, startup advice and what it is like to work as a Bioprocess Engineer.
Profile
When considering the significant industries in Norway, several obvious ones spring to mind: oil and gas, hydropower, property, and fishing. Life sciences would feature on very few lists, but that
In the heart of Iceland’s life sciences industry, Jonina Gudmundsdottir, the CEO of Coripharma, is making her mark. With a deep understanding of the industry’s challenges and a relentless drive
The CEO of Lundbeck, who announced that she will retire last week, did not initially intend to join the life science industry, but it captivated her more than 30 years
The latest research news from the Nordic region
Science articles
An international team of scientists led by the University of Helsinki performed comprehensive mapping of structural alterations in cellular proteins during the aging process. In the study published in Molecular
The 2023 Ig Nobel Prizes celebrates for example backward reading and counting nostril hairs. The 2023 Ig Nobel Prizes were awarded at the 33rd First Annual Ig Nobel Prize ceremony,
Researchers at Karolinska Institutet have developed a molecular method able to detect whether or not bacteria respond to antibiotics within minutes. The findings are presented in the journal Nature Microbiology
Professor Jens Juul Holst has made discoveries that have strongly influenced how people with obesity or type 2 diabetes are treated today. Throughout a long career, this internationally recognized researcher
Professor Åslaug Helland is the recipient of the King Olav Vs Cancer Research Award 2023. “This is a great honor, and I am very happy about this recognition of the
In January 2023, the European Association for the Study of Obesity (EASO) and the Novo Nordisk Foundation (NNF) announced that they were establishing a new prize for an agenda-setting researcher
Nordic Life Science
The latest clinical trials
Sign up to our newsletter